Nutrigenomics: Personalizing Weight Loss for Obese Veterans
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01859403|
Recruitment Status : Completed
First Posted : May 21, 2013
Last Update Posted : September 23, 2014
|Condition or disease||Intervention/treatment||Phase|
|Obesity||Genetic: Personalized Genomics||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||51 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Nutrigenomics: Personalizing Weight Loss for Obese Veterans|
|Study Start Date :||November 2012|
|Actual Primary Completion Date :||December 2013|
|Actual Study Completion Date :||March 2014|
Placebo Comparator: Usual Care
Usual care for veterans as part of the MOVE! program
Active Comparator: Personalized Genomics
Personalized genomics information from the FIT Test, Pathway Genomics
Genetic: Personalized Genomics
A set of single nucleotide polymorphisms in genes important for obesity, eating behaviors and exercise
Other Name: FIT test from Pathway Genomics, Inc.
- 5% weight loss [ Time Frame: 8 weeks ]Our primary hypotheses are that more obese veterans in the MOVE! program will lose greater or equal to 5% of their weight if they receive personalized genomic information and a genomically-derived diet built around packaged meals when compared to veterans in the same program that receive usual care during MOVE! and packaged meals after 8 weeks.
- 5% weight loss [ Time Frame: 24 weeks ]We hypothesize that more veterans in the genomic group that lose greater or equal to 5% weight loss at 8 weeks will maintain this weight loss after 24 weeks compared to veterans in the usual care group.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01859403
|United States, California|
|VA San Diego Healthcare System|
|San Diego, California, United States, 92161|